Compare ARK Genomic Revolution ETF (ARKG) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs VanEck Rare Earth/Strategic Metals — how do they compare? ARK Genomic Revolution ETF trades at $40.6, while VanEck Rare Earth/Strategic Metals trades at $77.59. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, VanEck Rare Earth/Strategic Metals nearer its low. Which is the better fit depends on your goals.
| ARKG | REMX | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $109.53 |
52-Week Low | $23.09 | $46.34 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
REMX trades at $79.76, down 0.34% with a bearish technical signal from moving averages but oversold RSI readings. Recent news highlights rare earth metals' strategic importance amid China's export controls and AI infrastructure demand. The ETF hit a 52-week high of $104.26 in April 2026 (Defense World, 2026-04-19), but current levels reflect a pullback from recent peaks.
Outlook hinges on commodity cycle momentum and geopolitical supply dynamics, offering growth exposure but with high volatility risks. Concentration in rare earths and lithium makes it sensitive to policy shifts and demand fluctuations, warranting cautious portfolio allocation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →
